MustGrow Biologics To Raise $2.0 Million In Private Placement
MustGrow Biologics (CSE: MGRO) this morning announced it will be conducting a small financing. The firm will look to raise
Read more
MustGrow Biologics
MustGrow: Organic Disease Control – The Daily Dive
Today on the Daily Dive, we welcome back Colin Bletsky, COO and Director of MustGrow Biologics Corp (CSE: MGRO). Colin
Read more
MustGrow Biologics Enters Exclusive Arrangement With Sumitomo Corp
It appears that MustGrow Biologics (CSE: MGRO) is on the right path with its proprietary mustard-based formulations. The company this
Read more
MustGrow Biologics Reports Positive Trial Results In Colombia
MustGrow Biologics (CSE: MGRO) this morning released further results from ongoing field trials being conducted on its products. The latest
Read more
MustGrow Biologics: NexusBioAg Partnership Validates Firms Research Program
Among current trends, governments around the world are banning the use of harmful pesticides and herbicide chemicals in agricultural production
Read more
MustGrow Sees Positive Results From Greenhouse Trials Against Root Rot Disease
MustGrow Biologics (CSE: MGRO) this morning reported the results of greenhouse trials with its mustard-derived biopesticide known as TerraMG. Trials
Read more
MustGrow Biologics To Collaborate With Univar Solutions On Field Trials
MustGrow Biologics (CSE: MGRO) is progressing with field trials for its TerraMG product. The company announced this morning that it
Read more
MustGrow Sees Positive Results From Tobacco Field Trials
MustGrow Biologics (CSE: MGRO) this morning reported on results for the use of its mustard-based biopesticide within tobacco field trials.
Read more
MustGrow Biologics Isolates Third Molecule From Mustard Plant
MustGrow Biologics (CSE: MGRO) continues to conduct research on the mustard plant and extract different molecules. The firm this morning
Read more
MustGrow Biologics Sees CannaPM Approved For Use Against Powdery Mildew In Cannabis And Hemp
It appears that revenues might be coming in the near term to MustGrow Biologics (CSE: MGRO). The company announced this
Read more